CTAG Dissection/Trauma Post Marketing Surveillance Japan

NCT05414318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2024-10-03

Study results available
· View outcomes & findings →

Summary

Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis

Conditions

  • Thoracic Aortic Aneurysm
  • Thoracic Aorta Injury
  • Thoracic Aortic Dissection

Interventions

DEVICE

Conformable GORE® TAG® Thoracic Endoprosthesis

Thoracic Endoprosthesis

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-05
Primary Completion
2022-12-23
Completion
2022-12-23
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05414318 on ClinicalTrials.gov